|Description:||New text has been added to the end of the additional information section: 'Some patients may be at increased risk of experiencing toxicity at therapeutic doses, particularly those with a body weight under 50 kg and those with risk factors for hepatotoxicity. Clinical judgement should be used to adjust the dose of oral and intravenous paracetamol in these patients.'|
|Date Update Posted Online:||January 6, 2017|
|Book:||Reference Edition, Pocket Book|
|Pocket Page Reference:||162|
|Guidelines PDF Update:||Click here to download PDF|
The ambulance response to the COVID-19 pandemic: what went well and how do we sustain the benefits?
Ambulance services, at the forefront of caring for patients within the pandemic setting, had...
NHSE&I and AACE launch Repository of Good Practice for Safely Reducing Ambulance Conveyance to Emergency Departments
Examples of initiatives that are working well and are being monitored, evaluated and shared...